Login
$LAB
$0.62 +$0.02 (2.68%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Michael Egholm, Ph.D. Also a director
President, Chief Executive Officer, and Director
63 Not stated Not stated $8,823,502
Alex Kim
Chief Financial Officer
55 Since 2024
2 years
2022 $4,005,165
Sean Mackay
Chief Business Officer
43 Since 2024
2 years
2024 $1,692,543

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
Not stated
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Egholm
Not stated Not stated Not independent None stated None stated Paid as CEO
Fenel M. Eloi
Not stated Not stated Independent
Audit Committee · Chair
None stated $269,322
Eli Casdin
Not stated Not stated Independent None stated None stated $261,322
Thomas Carey
Not stated Not stated Independent
Nominating and Corporate Governance Committee · Chair
None stated $359,322
Troy Cox
Not stated Not stated Independent None stated None stated $266,322
Kathy Hibbs
Not stated Not stated Independent None stated None stated $264,322
Frank Witney
Not stated Not stated Independent
Human Capital Committee · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 27, 2026
Mr. Casdin
a member of the Board
$5.0 million
December 9, 2025

Company invested $5.0 million in unsecured convertible loan notes of a privately-held life sciences company, alongside a fund associated with Mr. Casdin.

With a privately-held life sciences company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support